Prescriptions of CYP3A4‐ and P‐gp inducers for patients on direct oral anticoagulants: Bridging the gap between epidemiology and patient management for optimal thromboembolic event prevention

Ähnliche Einträge

• Pulmonary thromboembolism in an anticoagulated oncological patient
  von: Diana Alegre-González
  Veröffentlicht: (2023)
• Clinical characteristics and anticoagulation patterns of patients with acute pulmonary thromboembolism and hemoptysis
  von: Yiyao Li, et al.
  Veröffentlicht: (2024)
• Relevance of selected pharmacogenetic polymorphisms to bleeding and thromboembolic risks in Chinese patients taking direct‐acting oral anticoagulants
  von: Dongxu Wang, et al.
  Veröffentlicht: (2025)
• Extended treatment for venous thromboembolism: Is direct oral anticoagulant dose‐reduction better for all?
  von: Mandy N. Lauw, et al.
  Veröffentlicht: (2026)
• Knowledge patients receiving outpatient treatment on oral anticoagulation therapy
  von: Thaisa Remigio Figueirêdo
  Veröffentlicht: (2016)